Tokyo Medical and Dental University and Celaid Therapeutics Inc. joint research agreement on research and development of gene-modified cell therapy using human bone marrow hematopoietic stem cells (HSCs)
Tokyo Medical and Dental University (TMDU) and Celaid Therapeutics Inc. (Celaid) are pleased to announce the signing of a joint ...










